PIEZO2 Antibody [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-61130H
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Mouse
Applications
ELISA, Western Blot
Label
HRP
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Antibody was raised against a peptide corresponding to 19 amino acids near the amino terminus of human PIEZO2. Amino Acid Squence: HLTASLEKPEVRKLAEPGE
Reactivity Notes
Mouse reactivity reported from a verified customer review.
Specificity
PIEZO2 Antibody is predicted to not cross-react with PIEZO1.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for PIEZO2 Antibody [HRP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Peptide affinity purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PIEZO2
Long Name
PIEZO2
Alternate Names
C18orf30, C18orf58, DA3, DA5, DAIPT, FAM38B, FAM38B2, family with sequence similarity 38, member A pseud, family with sequence similarity 38, member B2, HsT748, HsT771, MWKS, piezo-type mechanosensitive ion channel component
Gene Symbol
PIEZO2
Additional PIEZO2 Products
Product Documents for PIEZO2 Antibody [HRP]
Product Specific Notices for PIEZO2 Antibody [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...